Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Long-Term Deferred Tax (2016 - 2026)

Amphastar Pharmaceuticals has reported Long-Term Deferred Tax over the past 13 years, most recently at $42.5 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax fell 40.3% year-over-year to $42.5 million; the TTM value through Dec 2025 reached $42.5 million, down 40.3%, while the annual FY2025 figure was $42.5 million, 40.3% down from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $42.5 million at Amphastar Pharmaceuticals, down from $71.1 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $71.1 million in Q4 2024 and troughed at $22.0 million in Q3 2021.
  • A 5-year average of $43.0 million and a median of $40.9 million in 2023 define the central range for Long-Term Deferred Tax.
  • Biggest five-year swings in Long-Term Deferred Tax: skyrocketed 82.45% in 2023 and later crashed 40.3% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $22.4 million in 2021, then surged by 72.0% to $38.5 million in 2022, then skyrocketed by 38.22% to $53.3 million in 2023, then soared by 33.56% to $71.1 million in 2024, then crashed by 40.3% to $42.5 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for AMPH at $42.5 million in Q4 2025, $71.1 million in Q3 2025, and $71.1 million in Q2 2025.